In large series of patients with cerebral tumours, papilloedema was present in 60%, and in supratentorial tumours in 50% of cases (Petrohelos and Henderson, 1951; Bregeat, 1956; Huber, 1956; Tonnis, 1959) . The presence of papilloedema is highly correlated with raised CSF pressure, and its absence is usually due to absence of sustained elevation of CSF pressure (van Crevel, 1975) . Therefore (with some qualifications, see Discussion), to understand the presence or absence of persistently raised CSF pressure is to understand the presence or absence of papilloedema in cerebral tumours.
Some brain tumours cause papilloedema, others, often quite as large, do not. This paper attempts to explain the main cause of that difference.
In large series of patients with cerebral tumours, papilloedema was present in 60%, and in supratentorial tumours in 50% of cases (Petrohelos and Henderson, 1951; Bregeat, 1956; Huber, 1956; Tonnis, 1959) . The presence of papilloedema is highly correlated with raised CSF pressure, and its absence is usually due to absence of sustained elevation of CSF pressure (van Crevel, 1975) . Therefore (with some qualifications, see Discussion) , to understand the presence or absence of persistently raised CSF pressure is to understand the presence or absence of papilloedema in cerebral tumours.
The approach to this problem has been dominated by the Monro-Kellie doctrine and its later elaborations. It was postulated that brain, blood, and CSF are incompressible and contained within a rigid skull, and that, therefore, all spaceoccupying lesions must lead to raised CSF pressure once the capacity for "compensation" -for example, by expulsion of CSF into the spinal theca-is exhausted (Langfitt, 1972) . If this were true for tumours, a high correlation should be found between tumour size and papilloedema. In fact, however, this correlation is low (Bregeat, 1956) or, according to some authors, absent (Tonnis and Krenkel, 1957) .
It should not be surprising that the MonroKellie doctrine and the implied simple relationship between intracranial volume and CSF pressure do not fit the facts in a slow process like the growth of a tumour. In the first place, given time, brain is compressible-that is, it atrophies, as is obvious from the large indentations produced by meningiomas. So, if brain atrophy should roughly equal tumour growth, the CSF pressure need not rise at all. Furthermore, in the MonroKellie concept, the CSF is regarded as a static component, whereas of course it is produced continually at a rate of some 500 ml/day (Davson, 1967; Milhorat, 1972) , and must be absorbed at the same rate if the CSF pressure is to stay normal. Therefore, the following hypothesis could be made. By obstructing CSF flow, a tumour, irrespective of its size, could lead to impaired CSF absorption at the superior sagittal sinus, and so to raised CSF pressure (Fig. 1B) ; but as long as the quantity of CSF reaching the superior sagittal sinus equals its production, CSF pressure need not necessarily rise (Fig. IC) . This hypothesis is examined in the present study for supratentorial tumours, by comparing the presence or absence of papilloedema, and the CSF pressure, with radioiodinated human serum albumin (RIHSA) cisternograms.
Patients and methods
Twenty-four patients were studied, 12 with and 12 without papilloedema ( (van Crevel, 1972) , signs of brainstem compression were regarded as a contraindication, but papilloedema was not. Cisternal puncture was performed with the patient almost supine, the shoulders raised and supported, the neck flexed, and the head resting against a special stand designed for pneumoencephalography (Ziedses des Plantes, 1950) . Apart from the puncture, the patients experienced no discomfort, and no complications occurred. The CSF pressure was measured with the shoulder as reference point; in a large number of cases this technique has been shown to produce values roughly equal to those of lumbar puncture in the lateral recumbent position.
Direct techniques are not available for measuring CSF absorption at the superior sagittal sinus in patients. Therefore, the amount of activity along the superior sagittal sinus on the RIHSA cisternograms 24 hours after injection was regarded as an index of the CSF absorption there. This was described on the anterior and lateral 24 hour scans, and rated as: normal or nearly normal, absent or nearly absent, and intermediate (+, -, and + in Table 1 ). After completion of the whole study, the rating was repeated without knowledge of the clinical data, with one change as a result. Examples of the three rating grades are shown in Fig. 2 .
Plasma RIHSA activity was measured 24 hours after cisternal injection, as an index of total CSF absorption.
Results

PAPILLOEDEMA AND CSF PRESSURE
Not unexpectedly, the correlation between papilloedema and raised CSF pressure was confirmed ( Fig. 3 ). Six patients without papilloedema had borderline or moderately raised CSF pressure, with a maximum of 300 mm water. Normal lumbar CSF pressure may range between 40 and 250 mm water (Gilland et al., 1974) . All patients with papilloedema had a CSF pressure above 300 mm water.
PAPILLOEDEMA AND CSF FLOW
The main result of this study is shown in Table 2 . The correlation between the presence of papilloedema and the reduction of RIHSA activity along the superior sagittal sinus at 24 hours is statistically significant (P<0.01, YatesCochran test). This supports the hypothesis that papilloedema in supratentorial tumours is mainly caused by severe obstruction of CSF flow, resulting in impaired absorption of CSF at the superior sagittal sinus.
The two patient groups are compared further in Table 3 . The age difference of more than 10 years is probably not fortuitous and will be discussed below. The type of tumour was not different for the two groups. Tumour size could be measured in 20 cases only, 10 in both groups. Though the mean size in the papilloedema group was slightly greater, the difference is not statistically significant, neither in each dimension Lundberg (1960) have revealed that in patients with cerebral tumours, the CSF pressure, continuously recorded, is subject to marked fluctuation. Our CSF pressure values represent single measurements made at chance moments. Nevertheless, they correlated surprisingly well to the absence or presence of papilloedema. Therefore the division into a "papilloedema" and a "no papilloedema" group, the former with higher CSF pressure than the latter, seems justified.
The idea that, in cerebral tumours, obstruction of CSF flow causes raised CSF pressure is of course not new, but has usually been applied only to intraventricular obstruction, and has not been investigated for subarachnoid CSF flow. This idea rests on the traditional concept of the CSF being secreted mainly within the ventricles, and drained mainly through the arachnoid villi and granulations into the superior sagittal sinus. This concept is still regarded as essentially correct, even though ventricular CSF production may be decreased with high CSF pressure (Milhorat, 1972; Pollay, 1977) .
Continuation of CSF production with cessation or severe impairment of CSF absorption in the superior sagittal sinus necessitates absorption by subsidiary routes. Such routes-for example, the basal sinuses and the spinal arachnoid villi-are known to exist, though their importance under normal circumstances is uncertain (Millen and Woollam, 1962; Davson, 1967; Kido et al., 1976) . Another possibility, in cases with hydrocephalus, is ventricular reabsorption (Milhorat, 1972; James et al., 1975 (Symon et al., 1972) . In experimental communicating hydrocephalus the CSF pressure is increased initially, but later falls into the normal range (James et al., 1975) . Hydrocephalus was present in case 6; in case 19 air studies were not done.
Two other patients (cases 9 and 21) did have papilloedema (CSF pressure 520 and 320 mm respectively), and yet "enough" RIHSA along the superior sagittal sinus. In this context, it should be remembered that CSF absorption through the arachnoid villi can be functionally impaired, while the subarachnoid CSF channels are anatomically patent. For example, in "benign intracranial hypertension" the CSF infusion test indicates impaired CSF absorption (Martins, 1973) , but RIHSA cisternography is normal (James et al., 1974) . Raised CSF pressure without obstruction of CSF pathways is also found in other conditions-for example, raised venous pressure or high CSF protein content. Case 21 had a CSF protein of 4.65 g/l; case 9 remains unexplained.
These speculations are mentioned in view of further investigation, and to stress that RIHSA cisternography is not a direct index of CSF absorption at the superior sagittal sinus.
FACTORS DETERMINING THE OCCURRENCE OF PAPILLOEDEMA IN CEREBRAL TUMOURS
In cerebral tumours, raised CSF pressure is necessary but not sufficient for the development of papilloedema (Table 4) . Raised CSF pressure must not only be present for a certain period of time, but the optic nerve sheaths must also be patent, as shown experimentally (Hayreh, 1968) . Unilateral or bilateral absence of papilloedema in cerebral tumours with raised CSF pressure may thus be caused by compression of the optic nerve sheath(s) by the tumour (Levatin, 1957) , or by congenital occlusion of the sheath(s) (Walsh and Hoyt, 1969) . Further, glaucoma (Bregeat, 1956) and severe myopia (Huber, 1956) (Moersch et al., 1941; Kloss, 1952) . This is usually explained by pre-existent brain atrophy, more space being available for the tumour. In the concept of CSF obstruction, more subarachnoid space would mean a smaller chance of CSF block. Whatever its explanation, the influence of age was confirmed in our series (Table 3) .
There was no significant difference in tumour type between our two groups (Table 3) . In large series, no consistent relationship between tumour type and incidence of papilloedema has been established either: Bregeat (1956) saw papilloedema more often in malignant, Huber (1956) in benign tumours, and the results of Tonnis (1959) were equivocal. Apparently, rapid growth of a tumour does not lead more often to CSF blocks than slow growth.
It would be surprising if the size of brain tumours had no influence at all on the incidence of papilloedema, but the correlation is low. In our two groups there was no statistically significant difference (Table 3) ; but the amount of brain shift (also dependent upon infiltrative versus expanding growth, oedema, and hydrocephalus) could not be measured, as no CAT scan was yet available. However, in view of our findings the total extra volume would be effective by obstruction of CSF flow rather than by "spaceoccupation" in itself. Papilloedema may even increase (and the CSF pressure may remain high) after removal of a tumour (Paton, 1905; Bynke and osterlin, 1960) . Again, this may be due to postoperative CSF blocks, as we could demonstrate by postoperative RIHSA cisternography in one patient (case 12) .
The site of a tumour relative to the CSF pathways must be important with regard to papilloedema. In large series, papilloedema was more frequent in frontal and temporal than in parietal lobe tumours (Br6geat, 1956; Huber, 1956; Tbnnis and Krenkel, 1957) , and in our small series this is also apparent (Table 1) . This may be due to the greater distance of parietal lobe tumours from the "strategic" CSF flow point-that is, the basal cisterns leading to the Sylvian fissures and the interhemispheric fissure. The high frequency of papilloedema in infratentorial, especially cerebellar, tumours is well known, but not self-evident. In current textbooks, it is usually attributed to the concomitant obstructive hydrocephalus (for example, Merritt, 1973) . Again, it is conceivable that this hydrocephalus causes increased CSF pressure by blocking the upward passage of CSF in the subarachnoid spaces at the tentorial hiatus, and not by simple "space-occupation." This was suggested long ago by Cairns (1939) , and demonstrated for hydrocephalus without tumour by RIHSA cisternography before and after a shunt by Milhorat (1972) . However, posterior fossa tumours may sometimes produce papilloedema but no hydrocephalus, and vice versa. This merits further investigation.
PAPILLOEDEMA AS A CLINICAL SIGN
In patients with brain tumours, papilloedema signifies that the CSF pressure has been raised for some time, usually because the CSF flow to the superior sagittal sinus is severely obstructed. Papilloedema gives no indication of the type of tumour, and very little of its size. Moreover, the relationship between the CSF pressure and the clinical state of the patient is erratic, as shown by continuous CSF pressure recording (Jennett and Johnston, 1972) .
Absence of papilloedema, if not caused by ophthalmological factors or time lag, merely means that the CSF pressure is not raised persistently, usually because CSF flow to the superior sagittal sinus is not severely obstructed. That, in itself, does not exclude extensive brain shifts or even brain herniation (Lundberg, 1960) .
As Miller and Adams (1972) have stressed, it is of vital importance not to equate raised CSF pressure with brain shift. Papilloedema is a reliable sign of raised CSF pressure, but neither papilloedema nor its absence are a clue to the presence, extent, or absence of brain shifts.
